People | October 01, 2022
Philips shareholders appoint Roy Jakobs as next President and CEO
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Transformation to pure-play Innovative Medicines company nears completion
The companies will leverage their respective proprietary technology platforms
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Subscribe To Our Newsletter & Stay Updated
